Preserve Evidence

Motiva Implant Safety: FDA Approval and BIA-ALCL Evidence (English)

Patients considering Motiva Preserve breast augmentation often ask one question first: "Is the implant safe?" This article summarizes what regulatory and peer-reviewed sources actually say. It is general information, and individual risk depends on personal factors.

Motiva Implant Safety: FDA Approval and BIA-ALCL Evidence (English)

FDA approval status

Motiva SmoothSilk Round and Round Ergonomix silicone gel-filled breast implants received U.S. FDA premarket approval (PMA), which reflects review of safety and effectiveness data for the approved indications (FDA PMA P230005). Approval defines indications and conditions of use; it does not eliminate the general risks of any implant surgery (FDA — Risks and Complications of Breast Implants).

Surface technology and the foreign body response

Implant surface topography influences how surrounding tissue responds. Research has examined how surface characteristics relate to the foreign body response (Nature Biomedical Engineering, 2021). Motiva's SmoothSilk/SilkSurface is positioned in this context (Motiva — Preserve), though surface alone does not determine an individual outcome.

모티바 프리저베 가슴성형, 어떤 수술인지 궁금하신가요? — 이미지성형외과 공식 홈페이지 바로가기

What the data say about BIA-ALCL

BIA-ALCL is a rare lymphoma that has been associated with breast implants, and the FDA maintains ongoing guidance and reporting (FDA — BIA-ALCL). The reported association has been linked predominantly to certain textured surfaces; risk profiles differ by implant type, and long-term surveillance continues. Patients should review current FDA guidance with their surgeon rather than rely on absolute claims.

이 글의 핵심Motiva Implant Safety:FDA Approval andBIA-ALCL Evidence…1FDA approval status2Surface technologyand the foreign bodyresponse3What the data sayabout BIA-ALCL4Multi-year clinicalfollow-up이미지성형외과

Multi-year clinical follow-up

Outcome analyses of Motiva Ergonomix implants over multiple years have been published (3-year outcomes, PRS 2018; 4-year interim safety, Aesthetic Plast Surg 2021). These describe cohort results and may help inform expectations, but they are not a promise of any individual result.

Disclaimer: This article provides general medical information and does not replace individual diagnosis or treatment. Outcomes, recovery, and complications vary by individual; please consult a qualified physician before deciding.

For a detailed Korean-language comparison of implant placement planes, see the prefascial vs subfascial plane guide (Korean).

이미지성형외과 제품이 궁금하신가요?

공식 사이트에서 확인하기

전화 문의: 02-539-9933

자주 묻는 질문

관련 글